Journal ArticleJ Pain Symptom Manage · June 2024
CONTEXT: Use of palliative care interventions in chronic obstructive pulmonary disease (COPD) has increased in recent years and inclusion criteria used to identify patients with COPD appropriate for palliative care vary widely. We evaluated the inclusion c ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · June 2024
CONTEXT: Driven by concerns about care quality, patient experience, and national metrics, health systems are increasingly focusing on identifying risk factors for patients who are hospitalized in the last month of life. OBJECTIVE: To evaluate patient facto ...
Full textLink to itemCite
Journal ArticleJAMA · April 23, 2024
IMPORTANCE: Falls are reported by more than 14 million US adults aged 65 years or older annually and can result in substantial morbidity, mortality, and health care expenditures. OBSERVATIONS: Falls result from age-related physiologic changes compounded by ...
Full textLink to itemCite
Journal ArticleHepatology communications · June 2023
BackgroundSymptom-focused trials are critically needed for patients with cirrhosis. However, this work would benefit from standard processes and validated measures.MethodsA writing group was formed among hepatologists, nurses, palliative ...
Full textOpen AccessCite
Journal ArticleJ Clin Oncol · March 10, 2023
PURPOSE: The COVID-19 pandemic-related disruptions in health care delivery might have affected end-of-life care in patients with cancer. We examined changes in place of death and hospice support for Medicaid and commercially insured patients during the pan ...
Full textLink to itemCite
Journal ArticleJ Med Econ · 2023
BACKGROUND: Real-world evidence is a valuable source of information in healthcare. This study describes the challenges and successes during algorithm development to identify cancer cohorts and multi-agent chemotherapy regimens from claims data to perform a ...
Full textLink to itemCite
Journal ArticleJ Oncol Pharm Pract · June 2022
BACKGROUND: Polypharmacy raises the risk of drug-drug interactions and adverse events among patients with cancer. Most polypharmacy research has focused on adults age 65 or older enrolled in Medicare insurance. To better inform pharmacy practice and cancer ...
Full textLink to itemCite
Journal ArticleAm J Hosp Palliat Care · August 2021
PURPOSE: Multimorbidity is associated with increased intensity of end-of-life healthcare. This association has been examined by number but not type of conditions. Our purpose was to understand how intensity of care is influenced by multimorbidity within sp ...
Full textLink to itemCite
Journal ArticleDrugs Real World Outcomes · June 2021
BACKGROUND: Data on short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilar utilization from claims data in the USA are limited. OBJECTIVE: To evaluate patient baseline characteristics and utilization patterns for short-acting G-C ...
Full textLink to itemCite
Journal ArticlePharmacol Res Perspect · February 2021
We report utilization patterns and characteristics of patients treated with biologic anti-inflammatory agents in a large commercially insured patient population in the United States. We identified adult (age ≥18 years) patients receiving biologic anti-infl ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · November 2018
CONTEXT: Limited data exist regarding how depression diagnosed at different times relative to a cancer diagnosis may affect healthcare utilization at end of life (EOL). OBJECTIVES: To assess the relationship between depression and health care utilization a ...
Full textLink to itemCite